ADAM8 and asthma: In agreement with this notion, our results seem to imply that BK-1361 may treat asthma through a mechanism of directly inhibiting ADAM8 activity on inflammatory cells, especially eosinophils, and thus reducing their ability to migrate into the bronchoalveolar space, consistent with its role in reducing cellular invasion in a PDAC mouse model24.